Pharmaceutical supply chains are expanding manufacturing infrastructure to meet surging global demand for metabolic and cardiovascular therapeutic agents.
Contract Development Scaling
Leading drug developers are deploying multi-billion-dollar capital investments into fill-finish facilities and API production. Third-party contract manufacturing organizations are securing long-term supply contracts, driving structural shifts in pharmaceutical capital expenditure allocations.